Chief Executive Officer
Leading the Future | Tech and Life Sciences Expertise
Our leadership team
Meet our world-class leadership team, each bringing decades of experience in emerging and established technologies, SaaS, and life sciences. Our trusted executives excel in navigating companies through rapid expansion, now applying their winning strategies to propel ArisGlobal into its next phase of growth. Discover more about our global experts below and explore career opportunities within our team.
Leadership team bios
Mladen Prenc2024-08-07T09:32:14+00:00
Aman Wasan
Chief Executive Officer
Aman Wasan is the CEO of ArisGlobal. Aman is a Scientist by training with a degree in Human Genomics. He has a deep knowledge of the Life Sciences industry, a well-established background in global leadership roles, and an expert in operational management and commercial leadership. Prior to taking the role of CEO, Aman served as Chief Commercial Officer for ArisGlobal, where he managed our commercial business and significantly scaled revenue. Since joining ArisGlobal in 2018, Aman has excelled in six different positions, including that of Head of Pharmacovigilance. Before joining the ArisGlobal team, Aman worked for Bioclinica as the company’s Global Head of Safety and Regulatory Services.
Mladen Prenc2024-08-07T10:17:34+00:00
Glenn Renzulli
President & Chief Financial Officer
Glenn brings more than 15 years of executive leadership across various industries. He has a strong background in scaling and supporting software and services businesses, as well as extensive M&A experience, including multiple exit transactions, public offerings, and acquiring and integrating new entities.
Before joining ArisGlobal, Glenn served as the CFO of Paya, an integrated payments company, where he led the team through a public listing and through its ultimate sale to Nuvei Corporation. Prior to that role, he was the CFO of Opus Global, a Risk & Compliance SaaS company serving the Fortune 100. At Opus Glenn was part of the management team that closed the transaction for the sale of Opus’ third-party risk management platform to Coupa Software. Glenn started his career at General Electric where he completed GE’s Financial Management Program.
Mladen Prenc2024-09-11T22:43:06+00:00
Ann-Marie Orange
CIO & Global Head of R&D
Ann-Marie brings more than 30 years of expertise to the ArisGlobal team and as CIO plays a pivotal role in driving the company’s technological development, fostering a results-driven culture, advising on the best solutions to stay ahead of the competition, optimizing processes, and capitalizing on emerging opportunities.
Ann-Marie came to ArisGlobal from TransUnion Euro, where she served as Chief Information Officer (CIO), leading and delivering the technology integration of Callcredit into TransUnion. She has a strong background in transforming the end-to-end technology lifecycles, leading global IT transformational projects, system integrations, and migration of products from on-premise to cloud, such as Azure and AWS.
Mladen Prenc2024-10-08T13:55:58+00:00
Steve Nuckols
Chief Customer Officer
Steve has a wealth of experience and a proven record of success in executive roles across the life sciences and healthcare technology sectors. He joined us from DNAnexus, a premier genomic data technology company, where he served as Chief Commercial Officer. Under his guidance, DNAnexus saw notable growth and innovation, with a strategic focus on supporting pharma, clinical diagnostics, and academic medical centers.
Previously, Steve served as Chief Revenue Officer at ArisGlobal for two years, significantly contributing to our growth and development. Before this, he was EVP and Chief Commercial Officer at ERT (now Clario), where as part of the original leadership team, he was instrumental in transforming and rapidly growing the company.
Mladen Prenc2024-10-08T13:34:41+00:00
Rajendra Hattarki
Chief Operating Officer
As COO, Raj Hattarki is responsible for overseeing ArisGlobal’s daily operations and executing its growth strategies. Raj’s leadership ensures that ArisGlobal continues to innovate while optimizing its operations to provide world-class products and services to its global client base.
Raj brings over two decades of expertise in life sciences, cloud technology, and consulting services, with a proven track record of ensuring customer success and operational excellence. Raj has built high performing teams driving technology transformations for many of the renowned Pharmaceutical, Biotech, Medical Device and CRO companies globally.
Prior to joining ArisGlobal as his second tenure, Raj worked with Veeva Systems and lead their Vault Safety services practice. Raj holds an Engineering degree from Gulbarga University, India.
dsturges@arisglobal.com2024-10-18T12:58:09+00:00
Chairman of the Board,
Amrit Ray, M.D., M.B.A.
Chairman of the Board,
Biopharmaceutical Executive, former Global President, Head of R&D and Medical at Pfizer, and Chief Medical Officer, Pharma, at Johnson & Johnson
Dr. Amrit Ray is a biopharmaceutical executive and physician researcher with a passion for advancing medical breakthroughs and championing healthcare access for patients. Dr. Ray is a Chairman and Board Director at a portfolio of visionary life sciences companies.
Dr. Ray has over 25 years of industry experience and held multiple C-suite roles at major global companies. He is the former Global President, Head of R&D and Medical, and ELT member at Pfizer Upjohn, and led all aspects of R&D in 90 countries and with responsibility as the company’s most senior decision-maker on patient matters. Previously, Dr. Ray was Chief Medical Officer and Chief Safety Officer for pharmaceuticals at Johnson & Johnson. He has championed clinical trials and access for well-known, groundbreaking medicines in Neuroscience, Oncology, Immunology and Cardio-Metabolism, and has sponsored >100 pioneering cross-sector healthcare partnerships.
Dr. Ray’s contributions to public health have been recognized by patients, governments, and academia. He has published widely and given invited expert input to the World Health Organization, U.S. Congress, U.K. MHRA and NICE, Gates Foundation, and other forums. Dr. Ray started his career serving as a hospital doctor in Britain’s National Health Service. He holds degrees in Immunology and in Medicine from Edinburgh University, and an MBA from Dartmouth College. Dr. Ray is as a Visiting Professor of Medical Sciences at Newcastle University, and a Board Trustee at the Hastings Center for bioethics.
Mladen Prenc2024-10-18T09:52:46+00:00
Board Member,
Daniel Berglund
Board Member,
Partner at Nordic Capital
Daniel Berglund is a member of ArisGlobal’s Board of Directors and a Partner at Nordic Capital, having joined the firm in January 2010. Daniel has served on the boards of nine Nordic Capital portfolio companies. Daniel focuses on investment situations within Technology and Payments as well has Healthcare IT. Before joining Nordic Capital, Daniel worked at Bain & CO from 2007 to 2009, most recently as a Senior Associate. Daniel holds an MSc in Economics from the Stockholm School of Economics and Business Administration from the Ross School of Business at the University of Michigan.
Mladen Prenc2024-10-18T09:52:59+00:00
Board Member,
Eric Jensen
Board Member,
Managing Director at Nordic Capital
Eric Jensen is a member of ArisGlobal’s Board of Directors and a Managing Director in the Operations Advisory Group at Nordic Capital. Previously, Eric was an entrepreneur and operator, serving as Chief Product Officer of AVIA, a digital health professional services firm which he co-founded, and as EVP of Health Systems Products and Strategy at Healthgrades. Eric started his career at McKinsey & Company where he served healthcare services clients as an Associate Partner. Eric holds an MBA from the University of Michigan and a B.S. degree in Chemical Engineering from The Ohio State University.
Mladen Prenc2024-10-18T09:52:52+00:00
Board Member,
Spencer Michelson
Board Member,
Manager at Nordic Capital
Spencer Michelson is a member of ArisGlobal’s Board of Directors and a Manager at Nordic Capital, having joined the firm in September 2022. Spencer has been deeply involved with seven different portfolio companies as a private equity investor, including three since he joined Nordic Capital. Prior to Nordic, Spencer was an investor for three years at GTCR, a private equity firm based in Chicago, IL, and an investment banker at Credit Suisse. Spencer holds an AB degree in Public & International Affairs from Princeton University.
Quick Links
Follow Us
© 2024 ArisGlobal – All Rights Reserved